Extract

This trial is conducted in Europe. The aim of the trial is to evaluate the change in disease activity following intravenous (i.v.) administration of two doses of NNC0114-0006 compared to placebo in subjects with active rheumatoid arthritis (RA) on background methotrexate (MTX) therapy.

Inclusion criteria

• Inflammation ,Rheumatoid Arthritis

Country

• Bulgaria
• Hungary
• Latvia
• Poland
• Russian Federation
• Serbia
• Spain

Links

• ictrp
• nct